2 authorised products containing Daratumumab, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| DARZALEX 1800 mg solution for injection EU/1/16/1101/004 |
Daratumumab | Janssen-Cilag International NV | — |
| DARZALEX 20 mg/mL concentrate for solution for infusion EU/1/16/1101/001-003 |
Daratumumab | Janssen-Cilag International NV | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.